India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers vying for a share of the fast-growing weight-loss treatment market, which analysts expect to reach $150 billion annually by the end of the decade
The 0.6 g/kg KAE group also had a higher hepatic T-AOC activity than the CON group, but the increase was less pronounced than that in the 0.4 g/kg KAE group
Commercial health plan coverage of GLP-1s for weight loss remains inconsistent
Real-time relationship between PKA biochemical signal network dynamics and increased action potential firing rate in heart pacemaker cells: kinetics of PKA activation in heart pacemaker cells
In practical terms, both medications are effective - but tirzepatide currently shows greater average weight loss at standard maximum doses in direct comparison trials
If youre a 90-pound woman, youre not going to like what happens. He pauses